| Summary: | Vaccines are urgently needed at the present time to protect humanity from COVID-19, which is caused by the Coronavirus 2 that causes severe acute respiratory syndrome. Large quantities of antibodies which have high affinity virus-neutralizing capability were induced by vaccines may optimally prevent infection and avoid unfavourable effects. During the progression of the vaccine, different vaccine models were assessed by disparate groups. This review summarizes the currently approved COVID- 19 vaccines with late-stage clinical results. The currently authorized SARS-CoV-2 vaccines with late stage clinical data are summarized in this review. Thrombosis may be related in some way to the vaccine, but the direct link has not yet been established. It was stressed that the probability of developing strokes is very small and does not compare with the benefit gained from using the vaccine at all.
|
|---|
